KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to -$427.0 million.

  • Gilead Sciences' Cash from Investing Activities rose 3985.92% to -$427.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 billion, marking a year-over-year increase of 1943.81%. This contributed to the annual value of -$3.4 billion for FY2024, which is 5227.37% down from last year.
  • Per Gilead Sciences' latest filing, its Cash from Investing Activities stood at -$427.0 million for Q3 2025, which was up 3985.92% from -$2.1 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Cash from Investing Activities ranged from a high of -$225.0 million in Q4 2024 and a low of -$2.2 billion during Q1 2024
  • Its 5-year average for Cash from Investing Activities is -$751.0 million, with a median of -$483.0 million in 2023.
  • As far as peak fluctuations go, Gilead Sciences' Cash from Investing Activities surged by 9690.32% in 2021, and later tumbled by 58925.08% in 2025.
  • Quarter analysis of 5 years shows Gilead Sciences' Cash from Investing Activities stood at -$278.0 million in 2021, then plummeted by 34.89% to -$375.0 million in 2022, then crashed by 93.87% to -$727.0 million in 2023, then skyrocketed by 69.05% to -$225.0 million in 2024, then tumbled by 89.78% to -$427.0 million in 2025.
  • Its last three reported values are -$427.0 million in Q3 2025, -$2.1 billion for Q2 2025, and -$415.0 million during Q1 2025.